BioNTech SE BNTX
NASDAQ BNTX
$98.57 -0.51 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Operating Leases (2018 - 2025)

Updated

BioNTech SE's Operating Leases came in at $268.08 million for Q4 2025, up 255.8% from $75.34 million a year earlier and up 10.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Operating Leases (2018 - 2025) Analysis & Trends

Going back to Q4 2018, BioNTech SE's Operating Leases data covers 10 quarters.

  • Going back by year, Operating Leases was $75.34 million in FY2024 (+22.4%) and $61.54 million in FY2023.
  • The Q4 2025 figure represents the highest quarterly Operating Leases in data going back to Q4 2018.
  • Business Quant data shows BNTX's Operating Leases at $241.99 million (Q3 2025), $260.46 million (Q2 2025) and $259.61 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioNTech SE 25.06 Bn -34.31 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 268.08 Mn
Sep 30, 2025 241.99 Mn
Jun 30, 2025 260.46 Mn
Mar 31, 2025 259.61 Mn
Dec 31, 2024 75.34 Mn
Dec 31, 2023 61.54 Mn
Jun 30, 2020 63.61 Mn
Dec 31, 2019 63.77 Mn
Sep 30, 2019 64.17 Mn
Dec 31, 2018 57.93 Mn
API Access

BioNTech SE Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BNTX&period=max&api_key=YOUR_API_KEY